166 related articles for article (PubMed ID: 34428522)
1. Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study.
Wang Z; Yu XL; Zhang J; Cheng ZG; Han ZY; Liu FY; Dou JP; Kong Y; Dong XJ; Zhao QX; Yu J; Liang P; Tang WZ
J Ethnopharmacol; 2021 Dec; 281():114539. PubMed ID: 34428522
[TBL] [Abstract][Full Text] [Related]
2. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial.
Chen Q; Shu C; Laurence AD; Chen Y; Peng BG; Zhen ZJ; Cai JQ; Ding YT; Li LQ; Zhang YB; Zheng QC; Xu GL; Li B; Zhou WP; Cai SW; Wang XY; Wen H; Peng XY; Zhang XW; Dai CL; Bie P; Xing BC; Fu ZR; Liu LX; Mu Y; Zhang L; Zhang QS; Jiang B; Qian HX; Wang YJ; Liu JF; Qin XH; Li Q; Yin P; Zhang ZW; Chen XP
Gut; 2018 Nov; 67(11):2006-2016. PubMed ID: 29802174
[TBL] [Abstract][Full Text] [Related]
3. Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis.
Luo S; Hu H
J Ethnopharmacol; 2023 Jan; 301():115774. PubMed ID: 36206867
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma Patients May Benefit From Postoperative Huaier Aqueous Extract After Liver Transplantation.
Lei JY; Yan LN; Zhu JQ; Wang WT
Transplant Proc; 2015 Dec; 47(10):2920-4. PubMed ID: 26707314
[TBL] [Abstract][Full Text] [Related]
5. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
6. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
[TBL] [Abstract][Full Text] [Related]
8. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract][Full Text] [Related]
9. Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial.
Chen Z; Chen HY; Lang QB; Li B; Zhai XF; Guo YY; Yue XQ; Ling CQ
Chin J Integr Med; 2012 May; 18(5):339-44. PubMed ID: 22549390
[TBL] [Abstract][Full Text] [Related]
10. Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation.
Hermida M; Preel A; Assenat E; Piron L; Cassinotto C; Ursic-Bedoya J; Guillot C; Herrero A; Panaro F; Pageaux GP; Guiu B
Hepatol Commun; 2021 Apr; 5(4):689-700. PubMed ID: 33860126
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH
Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596
[TBL] [Abstract][Full Text] [Related]
12. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
13. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.
Lee D; Chung YH; Kim JA; Park WH; Jin YJ; Shim JH; Ryu SH; Jang MK; Yu E; Lee YJ
Cancer; 2013 Jun; 119(12):2239-46. PubMed ID: 23564564
[TBL] [Abstract][Full Text] [Related]
15. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
[TBL] [Abstract][Full Text] [Related]
16. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
17. Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.
Yang H; Yang Y; Dou J; Cui R; Cheng Z; Han Z; Liu F; Yu X; Zhou X; Yu J; Liang P
Cancer Biol Med; 2020 May; 17(2):478-491. PubMed ID: 32587783
[No Abstract] [Full Text] [Related]
18. Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases.
Fukuhara T; Aikata H; Hyogo H; Honda Y; Morio K; Morio R; Hatooka M; Kobayashi T; Naeshiro N; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Chayama K
Eur J Radiol; 2015 Aug; 84(8):1540-1545. PubMed ID: 25979193
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
[TBL] [Abstract][Full Text] [Related]
20. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
